Treatment of indolent NHL by office-based haematologists in Germany: R-bendmustine replaces R-CHOP as “Standard of Care.”

Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2013.

Hematol Oncol 31 (Suppl. I)(Abstract 467), 248. doi:10.1002/hon.2059

Studie: TLN; Indikation: Hämoblastosen; Jahr: 2013; Veranstaltung: ICML; Journal: Hematological Oncology

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com